Tianjin Medical Journal ›› 2019, Vol. 47 ›› Issue (12): 1273-1276.doi: 10.11958/20191892

Previous Articles     Next Articles

Research progress in genetically modified adipose tissue-derived stem cells

ZHANG Jing-ying1, SUN Xiao-lin2, GENG Li-xia1△   

  1. 1 Department of Intensive Medicine, 2 Key Autoimmunity Laboratory of Inner Mongolia, Institute of Rheumatology, Department of Rheumatology, the First Affiliated Hospital of Baotou Medical College, Baotou 014010, China
  • Received:2019-07-01 Revised:2019-08-19 Published:2019-12-15 Online:2019-12-15
  • Supported by:
     

Abstract: Adipose mesenchymal stem cells (Adipose tissue-derived stem cells, ADSCs) are multidirectional differentiation potential cells from adipose tissue and are ideal sources of cell therapy. Genetically modified adipose mesenchymal stem cells not only have all the characteristics of ADSCs, but also can express some foreign genes efficiently and enhance their curative effect in the treatment of diseases, which brings a new opportunity for conventional clinical treatment of diseases which are difficult to cure. In this paper, the related progress in recent years is reviewed in order to provide reference for the application of gene modified ADSCs in clinical research.

Key words: adipose tissue-derived stem cells, gene modification, multiple differentiation, review

CLC Number: